✦ LIBER ✦

Impact of palivizumab on expected costs of respiratory syncytial virus infection in preterm infants: Potential for savings

✍ Scribed by Albert Marchetti; Helen Lau; Raf Magar; Liping Wang; Giovanna Devercelli

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness Of Prophylaxis Of Res

✍ Rosselli, D.; Rueda, J.D.; Ruiz, J.G. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Cost-effectiveness analysis of palivizum

✍ Kristian Neovius; Katharina Buesch; Kristina Sandström; Martin Neovius 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB

PIN35 COST-EFFECTIVENESS ANALYSIS OF PAL

✍ S Ikeda; M Kobayashi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Cost-Effectiveness Analysis of Palivizum

✍ Langenfeld, M.K.; Visser, S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost-effectiveness of potential infant v

✍ M.J. Meijboom; M.H. Rozenbaum; A. Benedictus; W. Luytjes; M.C.J. Kneyber; J.C. W 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 583 KB

PIN24 COST-EFFECTIVENESS OF RESPIRATORY

✍ L.B. Weiner; M.J. Polak; A. Masaquel; P.J. Mahadevia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB